If an eligible patient dies while being treated with an investigational drug, biological product, or device, the eligible patient's heirs are not liable for any outstanding debt related to the treatment, including any costs attributed to lack of insurance coverage for the treatment.
S.C. Code Ann. § 44-137-30
No liability to heirs for outstanding debt related to treatment with investigational drug, biological product, or device
2016 Act No. 230 (H.4542), SECTION 2, eff June 3, 2016.
Official source: South Carolina Legislature. Reproduced from public-domain South Carolina statutes; confirm against the official source for the current text. Not legal advice.